Stay updated on Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision history now shows Revision: v3.4.2 added and Revision: v3.4.1 removed, updating the record's version history.SummaryDifference0.0%

- Check20 days agoChange DetectedThe record history shows that Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedUI updates include showing the glossary and color-coding explanations; revision notes updated to v3.4.0 with No FEAR Act data references adjusted.SummaryDifference0.5%

- Check42 days agoChange DetectedThe record history gains a new revision entry v3.3.4, and the previous v3.3.3 entry is removed.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer/history.SummaryDifference0.1%

- Check91 days agoChange DetectedThis update only adds Revision: v3.3.2 and removes Revision: v3.2.0 from the study's version history, with no changes to study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.